Mark D. Smith - Director, Jazz Pharmaceuticals Plc
As of December 6, 2021
What is Mark D. Smith's Net Worth?
The current estimated net worth of Jazz Pharmaceuticals Plc's Director, Mark D. Smith, is estimated to be about $1.17M . Mark D. Smith owns about 4,419 units of Jazz Pharmaceuticals Plc common stock. In the last 5 months at Jazz Pharmaceuticals Plc, Mark D. Smith has sold an estimated value of $50.58K worth.
What is Mark D. Smith's Past Insider Trading?
Mark D. Smith's largest sale order was 417 units , worth over $50.58K on December 6, 2021. In total, Mark D. Smith has made about 2 transactions over 5 months of their time at Jazz Pharmaceuticals Plc. Mark D. Smith usually trades in December and August, with the busiest year in 2021.
Mark D. Smith
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Mark D. Smith's' Mailing Address?
- Mailing address is C/o Teladoc Health, Inc. 2 Manhattanville Road, Suite 203 Purchase NY 10577 NY
What are Jazz Pharmaceuticals Plc's Past Insider Trades?
Jazz Pharmaceuticals Plc's most recent insider trade came on June 10, 2022 by Samantha Pearce who sold 8,487 units worth $1.32M . In the last 15 years, insiders at Jazz Pharmaceuticals Plc have sold an estimated value of $1.63B and bought an estimated value of $84.59M worth of shares. Insider trading is most common in August, with the busiest year in 2014. The most active traders at the company are Bruce C Cozadd, Chairman & CEO, Michael Patrick Miller, EVP, and Patrick G Enright, Director .
Jazz Pharmaceuticals plc Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||